Pharma Centrum sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-07-17
Share capital
1,020,000.00 PLN
Registered address
132, 08-117 Oleśnica, Poland
Electronic delivery address
AE:PL-67754-74943-UBUSH-16

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk.

From the notes

Current income tax (CIT due)$1,870

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 82 days late). 4 of 6 audited by a statutory auditor.

  • 202507/07/2026
  • 202427/06/2025
  • 202329/06/2024
  • 202213/07/2023
  • 202105/10/2022
  • 202007/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 22%
Division · Retail trade1,696 / 9,997
Top 17%
Voivodeship · Mazowieckie7,642 / 76,953
Top 9.9%
Country · Poland28,561 / 297,266
Top 9.6%

Results vs industry

Revenue
This companyUSD 6.09mMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD 60.04kMedianUSD 21.22kAverageUSD 85.89k
Operating costs
This companyUSD 5.99mMedianUSD 1.88mAverageUSD 5.06m
Assets
This companyUSD 1.11mMedianUSD 545.50kAverageUSD 1.76m

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesmazowieckie1USD 0.00

Authorized Representatives

Damian Chaciak age 42 – President of the Management Board
Joanna Siennicka age 52 – Vice President of the Management Board
Michał Żuk age 57 – Attorney-in-fact (sole)

Manner of representation

In the case of a one-person management board, the member of the management board independently and the commercial proxy independently are authorised to perform legal acts and make declarations of will on behalf of the company. In the case of a multi-member management board, joint action by at least two members of the management board or by one member of the management board jointly with a commercial proxy is required to perform legal acts and make declarations of will on behalf of the company.

Supervisory board

Artur Jan Prusaczyk age 60 – Supervisory Board Member
Leszek Piotr Średziński age 52 – Supervisory Board Member
Paweł Żuk age 59 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
20,400$275,526.74100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2000-03-01.

  • ING Bank Śląski
    35 1050 1953 1000 0090 3066 3166
  • Bank spółdzielczy
    Bank spółdzielczy
    90 9221 0000 0132 2220 2000 0010
  • Alior Bank
    30 2490 0005 0000 4530 6746 9347

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 95,158

Public aid

6 public aid cases recorded, with a total value of $25,683.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,421
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,268
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,678

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
DR Zdrowie S.A.
Magmax S.A.
Adpharma sp. z o.o.
Novopharm - Miller sp. j.
Maglow S.A.
Farmacja Im. O. Klimuszki sp. z o.o.
Nuklover sp. z o.o.
Massmed sp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w Warszawie S.A.
Femaherb sp. z o.o.

Change history

DateEvent
2023-01-25Share capital increase
2018-01-03Address change
2018-01-03PKD change
2012-06-19Share capital increase
2009-11-03Share capital increase

FAQ

Last updated: 2026-10-07